Acquisition of Germany’s leading rehabilitation care provider


Median was founded by Erich Marx and Axel Steinwarz over 40 years ago and is the largest private rehabilitation care provider in Germany. Headquartered in Berlin, it owns and operates 27 rehabilitation and acute clinics at 19 locations throughout the country, including approximately 6,000 beds and employing around 4,500 staff.

The medical services offered at Median’s clinics are particularly focused on post acute rehabilitation. They include a wide range of areas, such as oncology, neurology, geriatrics, orthopaedics, cardiology and psychotherapy.

The conclusion of the acquisition follows many months of negotiations between Terence Cole and Mark Steinberg and Median’s founders, during which time a strong relationship has been established and the necessary confidence has been given with regards to the high level of services and integrity of the operation being maintained.

A number of professional advisors were appointed to assist in the acquisition, including Rothschild, McKinsey, Lovells, CB Richard Ellis and Ernst & Young, who between them undertook extensive evaluation of the current business and future expansion potential.

Partners Advent International, a Boston based hedge fund, were selected by MARCOL due to their knowledge and experience of the healthcare industry over the past 24 years. They recently acquired Craegmoor Healthcare, the UK’s largest independent provider for specialist care for adults and young people and prior to this they acquired Casa Reha, one of Germany’s largest nursing home operators.

Median is well positioned in terms of its geographic presence and treatment focus. The company’s growth will be supported by demographical factors and by increasing referral rates from acute care to rehabilitation. As the German rehabilitation market is highly fragmented it is believed that, in addition to organic growth, there will be excellent opportunities to explore add-on acquisitions that will further strengthen Median’s leading position in Germany.

The combination of MARCOL and Advent ideally places them both to grow Median’s current 27 clinics and expand upon their established operating procedures to further enhance efficiency and viability.

MARCOL will continue to consider substantial opportunities that are not only property focused, but may include operating companies with property interests and situations where the skills of its international asset management professionals can be utilised.

For further information on Median please visit:

www.median-kliniken.de.

More news >

Recent posts

MARCOL is pleased to share the announcement that Atida Group has joined CEPD, creating one of Europe’s leading pharmacy and digital health platforms.

MARCOL was a founding investor and remains a shareholder in Atida, supporting the business from its early development into a leading multi-national …

MARCOL, owner of Design Centre, Chelsea Harbour, is pleased to announce the launch of a new initiative: The Design Emporium Collective on Fifth

Launched in Spring 2026, the Design Emporium Collective introduces a multi-brand concept space within the Design Centre, Chelsea Harbour estate. …

WOW!house at Design Centre, Chelsea Harbour win the House & Garden Spotlight Award 2024

WOW!house at Design Centre, Chelsea Harbour has been honoured with the House & Garden Spotlight Award 2024. Hatta Byng, the editor of House & Garden, …

Space Plus opens two new stores for business in Bochum and Essen

New stores, Bochum and Essen adds up to 15000 sqm of storage space to the platform, further strengthening the brands market presence together with existing …

Terence Cole, our Co-Founder and Joint CEO of MARCOL, sadly passed away on Monday 19 December 2022, after a long illness.

Terence was a larger-than-life character who has left his mark on the world and touched many lives. He was tenacious, a great strategic thinker, …

MARCOL Executive Forum

We recently held our annual MARCOL Executive Forum, bringing together our senior team, and the CEOs and leadership of the MARCOL Portfolio companies: ALMCOR, Atida, …